Combination antiasthma agents
- Level
- Class
- Parent
- 51160000
- Below
- 43
- Links · KBLI
- 9
Definition
UNSPSC 51162000This classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called ASTHMA. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. Typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.
Same parent
Under 51160000 · 11Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.